Results 131 to 140 of about 501,321 (365)

Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open‐Label, Phase I Study

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Valemetostat tosylate (valemetostat) is a dual inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1, approved in Japan for the treatment of relapsed/refractory peripheral T‐cell lymphoma and adult T‐cell leukemia/lymphoma. This Phase I, open‐label study evaluated the pharmacokinetics and safety of a single 50‐mg oral dose of valemetostat in
Masaya Tachibana   +8 more
wiley   +1 more source

Immunomodulatory effect of hepatitis B virus (HBV) antigens and MRSA antigens on immune response

open access: yesMedical Journal of Babylon
Background: Methicillin-resistant Staphylococcus aureus is one of the most common human invaders and causes different types of illness worldwide.
Entidhar A. Hadi   +2 more
doaj   +1 more source

Hepatitis B Core Antigen: Immunology and Electron Microscopy [PDF]

open access: bronze, 1974
Lewellys F. Barker   +5 more
openalex   +1 more source

Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early‐Phase Clinical Study Participants

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Clascoterone is an androgen receptor inhibitor approved for the treatment of acne vulgaris in patients 12 years of age and older. Here, we report results of 5 phase 1 studies that assessed the pharmacokinetics (PK), safety, and skin irritation and sensitization potential of clascoterone cream 1% in healthy participants and patients with acne ...
Andrea Francesco Daniele Di Stefano   +8 more
wiley   +1 more source

Microtiter Solid-Phase Radioimmunoassay for Hepatitis B Antigen [PDF]

open access: gold, 1973
Robert H. Purcell   +3 more
openalex   +1 more source

Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences

open access: yesJournal of Virology, 1987
A. McLachlan   +6 more
semanticscholar   +1 more source

Expert Perspective: Hematologic Malignancies and Vasculitis

open access: yes
Arthritis &Rheumatology, EarlyView.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Prevalence of Antibodies to Hepatitis B Virus Antigens and Occult Hepatitis B Virus Infection in Blood Donors

open access: yesDiyala Journal of Medicine, 2019
Background: Occult hepatitis B virus (HBV) is the presence of HBV DNA in liver tissue and/or in serum in the absence of detectable hepatitis B surface antigen (HBsAg).
Abdulrazak SH Hasan
doaj   +2 more sources

Home - About - Disclaimer - Privacy